Fabio Barassi

发表

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

A. Marchetti, F. Buttitta, F. Cuccurullo, 2006, The Journal of pathology.

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.

A. Marchetti, F. Buttitta, A. Chella, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.

A. Marchetti, F. Buttitta, A. Gadducci, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation

A. Marchetti, F. Buttitta, A. Chella, 2002, Laboratory Investigation.

Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas

A. Marchetti, F. Buttitta, M. Barbareschi, 2007, Clinical Cancer Research.

Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features

Antonio Marchetti, Fabio Barassi, A. Marchetti, 2006, International journal of cancer.

Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung

Antonio Marchetti, Giuseppe Pelosi, Fabio Barassi, 2008, Human mutation.

Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.

A. Marchetti, F. Buttitta, F. Mancini, 2005, Cancer research.

Down Regulation of High in Normal-1 (HIN-1) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome

A. Marchetti, F. Buttitta, A. Chella, 2004, Clinical Cancer Research.

mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients

A. Marchetti, F. Buttitta, F. Mucilli, 2001, The Journal of pathology.

Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients

A. Marchetti, F. Buttitta, A. Chella, 2005, Clinical Cancer Research.

Survivin gene expression in early‐stage non‐small cell lung cancer

A. Marchetti, F. Buttitta, S. Bosari, 2003, The Journal of pathology.